tiprankstipranks
Trending News
More News >
bluebird bio (BLUE)
NASDAQ:BLUE
US Market

Bluebird Bio (BLUE) Financial Statements

Compare
2,844 Followers

Bluebird Bio Financial Overview

Bluebird Bio's market cap is currently $48.67M. The company's EPS TTM is $-2.98; its P/E ratio is ―; Bluebird Bio is scheduled to report earnings on May 7, 2025, and the estimated EPS forecast is $-2.52. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 83.81M$ 29.50M$ 3.60M$ 3.66M$ 250.73M
Gross Profit$ -5.57M$ -4.03M$ -6.48M$ -35.20M$ 245.34M
Operating Income$ -270.46M$ -244.26M$ -287.09M$ -590.91M$ -629.51M
EBITDA$ -156.82M$ -167.16M$ -215.56M$ -556.93M$ -553.63M
Net Income$ -240.72M$ -211.91M$ -266.58M$ -562.64M$ -618.70M
Balance Sheet
Cash & Short-Term Investments$ 62.30M$ 221.75M$ 181.74M$ 396.62M$ 1.27B
Total Assets$ 460.23M$ 619.16M$ 554.90M$ 593.79M$ 1.78B
Total Debt$ 358.24M$ 330.33M$ 281.39M$ 89.58M$ 193.02M
Net Debt$ 295.93M$ 108.57M$ 168.38M$ -71.58M$ -124.68M
Total Liabilities$ 491.77M$ 424.62M$ 358.56M$ 219.52M$ 426.20M
Stockholders' Equity$ -31.53M$ 194.54M$ 196.34M$ 374.28M$ 1.36B
Cash Flow
Free Cash Flow$ -262.62M$ -244.10M$ -366.16M$ -658.64M$ -499.34M
Operating Cash Flow$ -260.02M$ -235.05M$ -352.95M$ -635.64M$ -470.35M
Investing Cash Flow$ 3.90M$ 154.95M$ 250.45M$ 562.56M$ -84.34M
Financing Cash Flow$ 87.47M$ 196.25M$ 54.25M$ -93.95M$ 546.72M
Currency in USD

Bluebird Bio Earnings and Revenue History

Bluebird Bio Debt to Assets

Bluebird Bio Cash Flow

Bluebird Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis